deutsch
Company
ScheBo® • Biotech AG is an innovative biotech company that is active in the fields of drug development and the development, production and marketing of diagnostics.
Continuous innovation, strong customer focus and creative problem solving have made ScheBo® • Biotech AG a worldwide leading manufacturer of unique products.
Netanyastrasse 3
35394 Giessen, Germany
Phone +49 -(0)641 -4996-0
Fax +49 -(0)641 -4996-77
eMail: schebo@schebo.com
www.schebo.de
» Contact form
P.O. Box 6359
Basingstoke, RG22 4WE, UK
Phone +44-(0)1256-477259
Fax +44-(0)1256-327889
eMail: i.smith@schebo.com
www.schebo.co.uk
(Registered Office: Old Headmasters House, Unit 1, Building 1, Forest Business Centre, Fawley Road, Fawley, Southampton, SO45 1FJ, England. Registered in England number: 3749167)
PMB 168
445 E Cheyenne Mountain Blvd., Suite C
Colorado Springs, CO 80906
Phone (254) 371-6978
Fax (719) 358-9100
eMail: info@schebousa.com
www.schebo.com
Continuous innovation, strong customer focus and creative problem solving have made ScheBo® • Biotech AG a worldwide leading manufacturer of unique products.
Head office:
ScheBo® • Biotech AGNetanyastrasse 3
35394 Giessen, Germany
Phone +49 -(0)641 -4996-0
Fax +49 -(0)641 -4996-77
eMail: schebo@schebo.com
www.schebo.de
» Contact form
UK and Republic of Ireland:
ScheBo® • Biotech UK LimitedP.O. Box 6359
Basingstoke, RG22 4WE, UK
Phone +44-(0)1256-477259
Fax +44-(0)1256-327889
eMail: i.smith@schebo.com
www.schebo.co.uk
(Registered Office: Old Headmasters House, Unit 1, Building 1, Forest Business Centre, Fawley Road, Fawley, Southampton, SO45 1FJ, England. Registered in England number: 3749167)
USA und Canada:
ScheBo® • Biotech USA Inc.PMB 168
445 E Cheyenne Mountain Blvd., Suite C
Colorado Springs, CO 80906
Phone (254) 371-6978
Fax (719) 358-9100
eMail: info@schebousa.com
www.schebo.com
AEO-Certificate
The Main Customs Office of Giessen, Germany issued an AEO-F Certificate (Authorized Economic Operator – Customs Simplifications plus Security and Safety) to ScheBo Biotech AG on September 30, 2011.
read...
read...
Lecture DDW 2011: New molecular markers: M2-PK
Lecture of Prof. Dr. Sybille Mazurek on WEO/OMED Colorectal Cancer Screening Committee Meeting DDW 2011.
read...
read...
Biomarker ′M2-PK′ Identified as Key Enzyme in Cancer Diagnosis and Therapy
Ground Breaking Findings on Understanding Cancer Published in ′Science′
read...
read...
Video: Focus 2010 lecture on M2-PK
The high sensitivity (c.80%) and high specificity (>90%) of the M2-PK stool test for colorectal cancer screening and detection, plus benefits for patients, laboratories and doctors, was presented at Focus 2010
read...
read...
Tumour M2-PK as a stool marker for colorectal cancer
Comparative analysis in a large sample of unselected older adults vs colorectal cancer patients.
read...
read...
Coeliac disease and pancreatic exocrine insufficiency
The data have shown that pancreatic insufficiency, demonstrated by low faecal pancreatic elastase-1 levels, is common in adult coeliac disease patients.
read...
read...